Cisplatin half-life
WebSep 6, 2024 · Plasma concentrations of the parent compound, cisplatin, decay monoexponentially with a half-life of about 20 to 30 minutes following bolus … WebCisplatin is a platinum-based agent whose nephrotoxicity is thought related to the chloride in the cis position. Cisplatin gains entry into tubular cells via uptake by the OCT-2 …
Cisplatin half-life
Did you know?
WebSep 7, 2024 · A We can calculate the half-life of the reaction using Equation 14.5.3: t 1 / 2 = 0.693 k = 0.693 1.5 × 10 − 3 m i n − 1 = 4.6 × 10 2 m i n Thus it takes almost 8 h for half of the cisplatin to hydrolyze. B After 5 half-lives (about 38 h), the remaining concentration of cisplatin will be as follows: 0.053 M 2 5 = 0.053 M 32 = 0.0017 M WebNov 1, 2001 · Half life of cisplatin is 43 minutes with approximately 1/4th being eliminated within the first 24 hours (90% renal clearance). For carboplatin, IV bolus injection of 375mg/m2 leads to 39mg/mL concentration of drug initially, which declines to 9 mg/mL after 2 hours. Carboplatin is excreted in the urine, but not from the renal tubules.
WebNov 2, 2024 · Platinum-based chemotherapy can be effective in treating many different types of cancer. For example, cisplatin is one of the most effective drugs for ovarian cancer with as many as 80% of people ... WebCisplatin was found to bind to bovine erythrocyte-SOD at His19 with high selectivity as no other binding sites were identified. 83 Surprisingly, amine ligands as opposed to the chlorido ligand underwent ligand exchange reactions with His19 of SOD.
WebMay 1, 2024 · The major route of elimination of Carboplatin is renal excretion. Patients with creatinine clearances of approximately 60 mL/min or greater excrete 65% of the dose in … WebAbstract. Background: Cisplatin is a highly effective and frequently used drug in the chemotherapy of solid tumours in children, but only limited data are available on the …
WebMar 2, 2005 · The half-lives for total platinum and active drug were calculated by dividing 0.693 by the terminal rate constant. RESULTS Model-independent plasma ultrafiltrate and CSF pharmacokinetic variables for oxaliplatin, cisplatin and …
WebCisplatin is approved to be used alone or with other drugs to treat: Bladder cancer. It is used alone in patients with advanced cancer that cannot be treated with other therapies, such as surgery or radiation therapy. Ovarian cancer that has spread to other parts of the body. It is used with other drugs in patients who have already had surgery ... iot device gateway awsWebIn addition, the plasma elimination half-life of cisplatin is prolonged in renal failure. Caution should be exercised in patients with pre-existing renal dysfunction. Cisplatin is contraindicated in patients with serum creatinine levels greater than 0.2 mmol/L. Repeat courses are not advised until serum creatinine is below 0.14 mmol/L and/or ... on tv tonight ancWebCisplatin may be inadvisable if you have a history of severe allergic reaction to cisplatin, carboplatin, other platinum-containing formulations or mannitol. Do not receive any kind … iot device management using lifiWebDec 1, 1987 · Calculated pharmacokinetic parameters (peak concentrations, half-lives, areas under the curve) were compared with the corresponding values in patients at the … iot device breachesWebSep 18, 2024 · Its initial half-life is approximately 20 to 30 minutes, with a terminal half-life of 24 hours. ALbumin-bound platinum undergoes slow administration of minimally five days. Administration Cisplatin can be … iot device hackedWebSep 15, 2024 · Cisplatin is a prescription medicine used to treat the symptoms of cancer in the testicles (Metastatic Testicular Tumors), bladder (Advanced Bladder Cancer) and … on tv tonight area servedWebJan 12, 2024 · Administration of cilastatin suppressed cisplatin-induced kidney injury. (A) BALB/cA mice were administered cisplatin i.p. at a dose of 3 mg/kg or 6 mg/kg on days 0, 3 and 6.Mice that received 6 ... iot device management software open source